|
|
||||||||
The FASEB Journal, Vol 4, 2718-2725, Copyright © 1990 by The Federation of American Societies for Experimental Biology
REVIEWS |
MJ Welsh
Howard Hughes Medical Institute, Department of Internal Medicine and Physiology, University of Iowa College of Medicine, Iowa City 52242.
Cystic fibrosis (CF), the most common lethal genetic disease in Caucasians, is characterized by defective electrolyte transport in several epithelia. In sweat duct, pancreatic, intestinal, and airway epithelia, abnormalities in transepithelial ion transport may account for the manifestations of the disease. A Cl- impermeable apical cell membrane is a common feature in these CF epithelia. The rate of transepithelial Cl- transport is controlled in part by hormonally regulated apical membrane Cl- channels; in CF epithelia, Cl- channels are present but their regulation is defective. Most regulation studies have focused on an outwardly rectifying Cl- channel, although other channels may be involved in Cl- secretion. Phosphorylation of Cl- channels or associated regulatory proteins by cAMP-dependent protein kinase or by protein kinase C (at a low internal [Ca2+]) in excised patches of membrane activates Cl- channels in normal cells but not in CF cells. Phosphorylation with protein kinase C at a high internal [Ca2+] in excised patches of membrane inactivates the channel; such inactivation is normal in CF cells. Cl- channels can also be activated by other maneuvers including an increase in the cytosolic [Ca2+], sustained membrane depolarization, an increase in temperature, proteolysis, and changes in osmolarity; the response to such maneuvers is not defective in CF. In addition to the Cl- channel abnormalities, Na+ absorption is increased in CF epithelia. It is not certain whether the increased rate of Na+ absorption results from an increase in the number of cation channels or an alteration of their kinetics. The relation of these ion channel abnormalities to the CF gene product is unknown, but an understanding of the function of the protein product and its defective function in CF should yield important new insights into the pathogenesis and potential therapy of this disease.
This article has been cited by other articles:
![]() |
A. J. Hirsh, J. Zhang, A. Zamurs, J. Fleegle, W. R. Thelin, R. A. Caldwell, J. R. Sabater, W. M. Abraham, M. Donowitz, B. Cha, et al. Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 77 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Bruscia, E. C. Ziegler, J. E. Price, S. Weiner, M. E. Egan, and D. S. Krause Engraftment of Donor-Derived Epithelial Cells in Multiple Organs Following Bone Marrow Transplantation into Newborn Mice Stem Cells, October 1, 2006; 24(10): 2299 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Bruscia, J. E. Price, E.-C. Cheng, S. Weiner, C. Caputo, E. C. Ferreira, M. E. Egan, and D. S. Krause Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation PNAS, February 21, 2006; 103(8): 2965 - 2970. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wang, B. A. Bunnell, R. G. Painter, B. C. Quiniones, S. Tom, N. A. Lanson Jr, J. L. Spees, D. Bertucci, A. Peister, D. J. Weiss, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: Potential therapy for cystic fibrosis PNAS, January 4, 2005; 102(1): 186 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. McShane, J.C. Davies, T. Wodehouse, A. Bush, D. Geddes, and E.W.F.W. Alton Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect Eur. Respir. J., July 1, 2004; 24(1): 95 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.P. Hauber, A. Tsicopoulos, B. Wallaert, S. Griffin, N.G. McElvaney, P. Daigneault, Z. Mueller, R. Olivenstein, K.J. Holroyd, R.C. Levitt, et al. Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Eur. Respir. J., June 1, 2004; 23(6): 846 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. McShane, J.C. Davies, M.G. Davies, A. Bush, D.M. Geddes, and E.W.F.W. Alton Airway surface pH in subjects with cystic fibrosis Eur. Respir. J., January 1, 2003; 21(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. S. Rao, R. E. Steimle, and P. Balachandran Activation of Large Conductance Sodium Channels upon Expression of Amiloride-sensitive Sodium Channel in Sf9 Insect Cells J. Biol. Chem., February 8, 2002; 277(7): 4900 - 4905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Smitham and K. E. Barrett Differential effects of apical and basolateral uridine triphosphate on intestinal epithelial chloride secretion Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1431 - C1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. LEPPLE-WIENHUES, U. WIELAND, T. LAUN, L. HEIL, M. STERN, and F. LANG A src-like kinase activates outwardly rectifying chloride channels in CFTR-defective lymphocytes FASEB J, April 1, 2001; 15(6): 927 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. McCarty Permeation through the CFTR chloride channel J. Exp. Biol., January 7, 2000; 203(13): 1947 - 1962. [Abstract] [PDF] |
||||
![]() |
J. R. Hume, D. Duan, M. L. Collier, J. Yamazaki, and B. Horowitz Anion Transport in Heart Physiol Rev, January 1, 2000; 80(1): 31 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qian, D. Okuhara, M. K. Abe, and M. R. Rosner Molecular Cloning and Characterization of a Mitogen-activated Protein Kinase-associated Intracellular Chloride Channel J. Biol. Chem., January 15, 1999; 274(3): 1621 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, D. Wang, H. Fischer, P.-d. Fan, J. H. Widdicombe, Y. W. Kan, and J.-y. Dong Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes PNAS, August 18, 1998; 95(17): 10158 - 10163. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tirouvanziam, M. Desternes, A. Saari, E. Puchelle, B. Peault, and T. Chinet Bioelectric properties of human cystic fibrosis and non-cystic fibrosis fetal tracheal xenografts in SCID mice Am J Physiol Cell Physiol, April 1, 1998; 274(4): C875 - C882. [Abstract] [PDF] |
||||
![]() |
E. DENEUVILLE, C. PERROT-MINOT, F. PENNAFORTE, M. ROUSSEY, J.-M. ZAHM, C. CLAVEL, E. PUCHELLE, and S. de BENTZMANN Revisited Physicochemical and Transport Properties of Respiratory Mucus in Genotyped Cystic Fibrosis Patients Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 166 - 172. [Abstract] [Full Text] |
||||
![]() |
L Rochwerger, S Dho, L Parker, J. Foskett, and M Buchwald Estrogen-dependent expression of the cystic fibrosis transmembrane regulator gene in a novel uterine epithelial cell line J. Cell Sci., January 9, 1994; 107(9): 2439 - 2448. [Abstract] [PDF] |
||||
![]() |
C Jiang, W. Finkbeiner, J. Widdicombe, P. McCray Jr, and S. Miller Altered fluid transport across airway epithelium in cystic fibrosis Science, October 15, 1993; 262(5132): 424 - 427. [Abstract] [PDF] |
||||
![]() |
L. L. Clarke, B. R. Grubb, S. E. Gabriel, O. Smithies, B. H. Koller, and R. C. Boucher Defective Epithelial Chloride Transport in a Gene-Targeted Mouse Model of Cystic Fibrosis Science, August 21, 1992; 257(5073): 1125 - 1128. [Abstract] [PDF] |
||||
![]() |
F. Collins Cystic fibrosis: molecular biology and therapeutic implications Science, May 8, 1992; 256(5058): 774 - 779. [Abstract] [PDF] |
||||
![]() |
M. Anderson, R. Gregory, S Thompson, D. Souza, S Paul, R. Mulligan, A. Smith, and M. Welsh Demonstration that CFTR is a chloride channel by alteration of its anion selectivity Science, July 12, 1991; 253(5016): 202 - 205. [Abstract] [PDF] |
||||
![]() |
M. Anderson, D. Rich, R. Gregory, A. Smith, and M. Welsh Generation of cAMP-activated chloride currents by expression of CFTR Science, February 8, 1991; 251(4994): 679 - 682. [Abstract] [PDF] |
||||
![]() |
M. A. Carew, X. Yang, C. Schultz, and S. B. Shears myo-Inositol 3,4,5,6-Tetrakisphosphate Inhibits an Apical Calcium-activated Chloride Conductance in Polarized Monolayers of a Cystic Fibrosis Cell Line J. Biol. Chem., August 25, 2000; 275(35): 26906 - 26913. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |